Skip to main content
. 2020 May 15;201(10):1230–1239. doi: 10.1164/rccm.201909-1834OC

Table 3.

Patient Characteristics at Enrollment and during Follow-up, by Interstitial Lung Disease Event Type

  ILD Events
No Event (n = 104)
Developed Clinical ILD or Extensive ILA (n = 12) ILA Progressed on HRCT 2 (n = 13)
Characteristics at enrollment
 Age, yr, mean (SD) 59.7 (12.2) 53.4 (9.6) 51.6 (7.3)
 Sex, F, n (%) 6 (50) 4 (31) 69 (66)
 Ever smoker, n (%) 5 (42) 6 (46) 26 (25)
MUC5B GT or TT, n (%) 5 (42) 5 (39) 30 (29)
 TRF length, kb, mean (SD) 6.17 (1.07) 6.26 (0.96) 6.47 (1.04)
 HRCT findings      
  ILA category, n (%)      
   None 0 (0) 6 (46.2) 93 (89)
   Early/mild 12 (100) 7 (53.9) 11 (11)
  Honeycombing, n (%) 3 (25) 0 (0) 0 (0)
  Ground-glass opacities, n (%) 4 (33) 1 (7.7) 5 (5)
  Intralobular reticular opacities, n (%) 12 (100) 5 (39) 7 (7)
  Irregular septal thickening, n (%) 10 (83) 4 (31) 4 (4)
  Traction bronchiectasis, n (%) 0 (0) 0 (0) 0 (0)
  Traction bronchiolectasis, n (%) 1 (8) 0 (0) 1 (1)
  Bilateral interstitial features, n (%) 9 (75) 3 (23) 4 (4)
  Visual ILA score, median (Q1–Q3) 5.0 (3.5–12.0) 0 (0–2) 0 (0–0)
  DTA score, median (Q1–Q3) 3.8 (1.0–9.3) (n = 11) 1.0 (0.7–1.5) (n = 13) 0.8 (0.4–1.4) (n = 100)
Characteristics during longitudinal follow-up
 Second HRCT findings n = 6 n = 13 n = 67
  Inter-HRCT interval, yr, median (Q1–Q3) 5.7 (3.8–6.2) 5.3 (5.0–5.7) 5.0 (3.6–6.2)
  ILA category, n (%)      
   None 0 (0) 1 (7.7) 65 (97.0)
   Early/mild ILA 2 (33.3) 12 (92.3) 2 (3.0)
   Extensive ILA 4 (66.7) 0 (0) 0 (0)
  Honeycombing, n (%) 2 (33) 1 (7.7) 0 (0)
  Bilateral interstitial features, n (%) 6 (100) 8 (61.5) 0 (0)
  Visual ILA score, median (Q1–Q3) 24.5 (15.0–27.0) 6.0 (2.0–13.0) 0 (0–0)
  DTA score, median (Q1–Q3) n/a (n = 1) 2.2 (0.7–4.1) (n = 12) 0.6 (0.4–1.3) (n = 62)
 Yearly change in dyspnea score, mean (SD) 0.2 (0.5) (n = 10) 0.04 (0.1) −0.04 (0.2) (n = 89)
 Yearly change in visual ILA score, mean (SD) 3.7 (1.7) (n = 6) 0.8 (0.6) −0.05 (0.3) (n = 67)
 Yearly change in DTA score, mean (SD) n/a (n = 1) 0.36 (0.55) (n = 12) −0.09 (0.62) (n = 62)

Definition of abbreviations: DTA = data-driven textural analysis; HRCT = high-resolution computed tomography; ILA = interstitial lung abnormalities; ILD = interstitial lung disease; n/a = not applicable (mean yearly change not calculated for one subject with available data); Q1–Q3 = interquartile range; TRF = telomere restriction fragment.

n = 129 subjects, except where noted. Continuous values are given as mean (SD) or median (interquartile range).